HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kerstin Hall Selected Research

Insulin-Like Growth Factor Binding Protein 1

12/2014The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus.
3/2013Leptin may enhance hepatic insulin sensitivity in children and women born small for gestational age.
12/2012Differences in insulin resistance markers between children born small for gestational age or born preterm appropriate for gestational age.
8/2010IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women.
12/2009IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma.
12/2008Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.
3/2005Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.
4/2003Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kerstin Hall Research Topics

Disease

8Insulin Resistance
01/2015 - 04/2003
4Type 2 Diabetes Mellitus (MODY)
12/2014 - 03/2005
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2014 - 08/2010
1Psychotic Disorders (Schizoaffective Disorder)
01/2015
1Schizophrenia (Dementia Praecox)
01/2015
1Obesity
12/2014
1Inflammation (Inflammations)
12/2014
1Retinopathy of Prematurity (Retrolental Fibroplasia)
02/2014
1Lipodystrophy
03/2013
1Prolactinoma (Prolactinomas)
09/2011
1Hyperprolactinemia
09/2011
1Osteoporosis
11/2010
1Abdominal Obesity
08/2010
1Multiple Myeloma
12/2009
1Dermatitis
12/2009
1Hepatocellular Carcinoma (Hepatoma)
04/2003
1Hepatoblastoma
06/2002

Drug/Important Bio-Agent (IBA)

8Insulin-Like Growth Factor Binding Protein 1IBA
12/2014 - 04/2003
7Insulin (Novolin)FDA Link
12/2014 - 04/2003
3Insulin-Like Growth Factor Binding ProteinsIBA
12/2014 - 06/2002
2Amino AcidsFDA Link
01/2015 - 11/2010
2Glucose (Dextrose)FDA LinkGeneric
12/2008 - 03/2005
1Antipsychotic Agents (Antipsychotics)IBA
01/2015
1Clozapine (Clozaril)FDA LinkGeneric
01/2015
1Glutamic Acid (Glutamate)FDA Link
01/2015
1Tyrosine (L-Tyrosine)FDA Link
01/2015
1Insulin-Like PeptidesIBA
12/2014
1Growth Hormone (Somatotropin)IBA
12/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2014
1LeptinIBA
03/2013
1LipidsIBA
09/2011
1Dopamine Agonists (Dopamine Agonist)IBA
09/2011
1ProlactinIBA
09/2011
1Hormones (Hormone)IBA
11/2010
1Peptide Hydrolases (Proteases)FDA Link
12/2009
1Triglycerides (Triacylglycerol)IBA
12/2008
1HDL CholesterolIBA
12/2008
1C-PeptideIBA
12/2008
12,4-thiazolidinedione (thiazolidinedione)IBA
04/2003
1Troglitazone (Rezulin)FDA Link
04/2003
1PPAR gammaIBA
04/2003
1PPAR alphaIBA
04/2003
1Proteins (Proteins, Gene)FDA Link
06/2002

Therapy/Procedure

1Aftercare (After-Treatment)
09/2011
1Therapeutics
09/2011
1Caloric Restriction
03/2005